185 related articles for article (PubMed ID: 19201737)
1. A newly proposed semi-automated method of grading invasive lobular carcinoma: a unifying concept and correlation with prognostic markers and patient survival.
Stevens E; Kimler BF; Davis MK; Fan F; Thomas P; Wang XY; Damjanov I; Tawfik OW
Ann Clin Lab Sci; 2009; 39(1):25-31. PubMed ID: 19201737
[TBL] [Abstract][Full Text] [Related]
2. Does routine grading of invasive lobular cancer of the breast have the same prognostic significance as for ductal cancers?
Sinha PS; Bendall S; Bates T
Eur J Surg Oncol; 2000 Dec; 26(8):733-7. PubMed ID: 11087636
[TBL] [Abstract][Full Text] [Related]
3. Grading invasive ductal carcinoma of the breast: advantages of using automated proliferation index instead of mitotic count.
Tawfik O; Kimler BF; Davis M; Stasik C; Lai SM; Mayo MS; Fan F; Donahue JK; Damjanov I; Thomas P; Connor C; Jewell WR; Smith H; Fabian CJ
Virchows Arch; 2007 Jun; 450(6):627-36. PubMed ID: 17458558
[TBL] [Abstract][Full Text] [Related]
4. Histologic grading of invasive lobular carcinoma: does use of a 2-tiered nuclear grading system improve interobserver variability?
Adams AL; Chhieng DC; Bell WC; Winokur T; Hameed O
Ann Diagn Pathol; 2009 Aug; 13(4):223-5. PubMed ID: 19608079
[TBL] [Abstract][Full Text] [Related]
5. Cytohistological correlation of grading in breast carcinoma.
Lingegowda JB; MuddeGowda PH; Ramakantha CK; Chandrasekar HR
Diagn Cytopathol; 2011 Apr; 39(4):251-7. PubMed ID: 21416638
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the prognostic value of Scarff-Bloom-Richardson and Nottingham histological grades in a series of 825 cases of breast cancer: major importance of the mitotic count as a component of both grading systems.
Genestie C; Zafrani B; Asselain B; Fourquet A; Rozan S; Validire P; Vincent-Salomon A; Sastre-Garau X
Anticancer Res; 1998; 18(1B):571-6. PubMed ID: 9568179
[TBL] [Abstract][Full Text] [Related]
7. Scarff-Bloom-Richardson (SBR) grading: a pleiotropic marker of chemosensitivity in invasive ductal breast carcinomas treated by neoadjuvant chemotherapy.
Amat S; Penault-Llorca F; Cure H; Le Bouedëc G; Achard JL; Van Praagh I; Feillel V; Mouret-Reynier MA; Dauplat J; Chollet P
Int J Oncol; 2002 Apr; 20(4):791-6. PubMed ID: 11894126
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of proliferating cell nuclear antigen (PCNA) in infiltrating ductal carcinoma breast.
Aziz SA; Pervez S; Khan SM; Kayani N; Nasir MI
J Coll Physicians Surg Pak; 2005 Apr; 15(4):225-9. PubMed ID: 15857596
[TBL] [Abstract][Full Text] [Related]
9. Is survival from infiltrating lobular carcinoma of the breast different from that of infiltrating ductal carcinoma?
Jayasinghe UW; Bilous AM; Boyages J
Breast J; 2007; 13(5):479-85. PubMed ID: 17760669
[TBL] [Abstract][Full Text] [Related]
10. Grading system for lymph vessel tumor emboli for prediction of the outcome of invasive ductal carcinoma of the breast.
Hasebe T; Yamauchi C; Iwasaki M; Ishii G; Wada N; Imoto S
Hum Pathol; 2008 Mar; 39(3):427-36. PubMed ID: 18261627
[TBL] [Abstract][Full Text] [Related]
11. Classification and grading of invasive breast carcinoma.
Elston CW
Verh Dtsch Ges Pathol; 2005; 89():35-44. PubMed ID: 18035670
[TBL] [Abstract][Full Text] [Related]
12. Introduction of the cytological grading, the nuclear area, the DNA index and the DNA histogram type in the setting up of a score for ductal breast carcinoma.
Budel V; Merle S; Gasperin P; Collet JF; De Maublanc MA; Kiss R
Anticancer Res; 1994; 14(6B):2845-51. PubMed ID: 7532932
[TBL] [Abstract][Full Text] [Related]
13. Comparative predictive value of three prognostic markers--S-phase fraction, PCNA and Mitotic count on axillary lymph node metastasis in carcinoma breast.
Pervez S; Khan MN; Nasir MI
J Ayub Med Coll Abbottabad; 2007; 19(1):3-5. PubMed ID: 17867469
[TBL] [Abstract][Full Text] [Related]
14. The biological and prognostic significance of cell polarity and E-cadherin in grade I infiltrating ductal carcinoma of the breast.
Tan DS; Potts HW; Leong AC; Gillett CE; Skilton D; Harris WH; Liebmann RD; Hanby AM
J Pathol; 1999 Sep; 189(1):20-7. PubMed ID: 10451483
[TBL] [Abstract][Full Text] [Related]
15. Tumor characteristics and patient outcomes are similar between invasive lobular and mixed invasive ductal/lobular breast cancers but differ from pure invasive ductal breast cancers.
Bharat A; Gao F; Margenthaler JA
Am J Surg; 2009 Oct; 198(4):516-9. PubMed ID: 19800459
[TBL] [Abstract][Full Text] [Related]
16. Breast infiltrating ductal carcinoma: analysis of hormone, HER-2 receptors and Ki-67 proliferation marker.
Mustać E; Zamolo G; Petković M; Dordević G; Radić J; Grgurević E; Batinac T
Coll Antropol; 2008 Sep; 32(3):741-6. PubMed ID: 18982746
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the prognostic significance of current and modified histological grades in breast carcinomas.
Charpin C; Bacquie N; Bouvier C; Devictor B; Boulat J; Andrac L; Lavaut MN; Allasia C; Piana L
Anticancer Res; 1995; 15(6B):2611-7. PubMed ID: 8669834
[TBL] [Abstract][Full Text] [Related]
18. Invasive lobular breast cancer. Prognostic significance of histological malignancy grading.
Talman ML; Jensen MB; Rank F
Acta Oncol; 2007; 46(6):803-9. PubMed ID: 17653904
[TBL] [Abstract][Full Text] [Related]
19. Survival analysis between patients with invasive ductal and invasive lobular breast cancer.
Dian D; Herold H; Mylonas I; Scholz C; Janni W; Sommer H; Friese K
Arch Gynecol Obstet; 2009 Jan; 279(1):23-8. PubMed ID: 18449551
[TBL] [Abstract][Full Text] [Related]
20. Prospective multicenter comparison of proliferation and other prognostic factors in lymph node negative lobular invasive breast cancer.
Gudlaugsson E; Skaland I; Janssen EA; van Diest PJ; Voorhorst FJ; Kjellevold K; zur Hausen A; Baak JP
Breast Cancer Res Treat; 2010 May; 121(1):35-40. PubMed ID: 19568929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]